Trastuzumab

From Citizendium, the Citizens' Compendium
Jump to: navigation, search
This article is a stub and thus not approved.
Main Article
Talk
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and not meant to be cited; by editing it you can help to improve it towards a future approved, citable version. These unapproved articles are subject to a disclaimer.

In medicine and chemotherapy, trastuzumab (pronounced tras too' zoo mab), Herceptin ®, is a monoclonal antibody against the ErbB-2 receptor (HER2) that lengthens remission time in metastatic breast cancer.[1]

External links

The most up-to-date information about Trastuzumab and other drugs can be found at the following sites.


References

  1. Hudis CA (2007). "Trastuzumab--mechanism of action and use in clinical practice.". N Engl J Med 357 (1): 39-51. DOI:10.1056/NEJMra043186. PMID 17611206. Research Blogging.